FDA Inspection 1308838 — Cerovene Inc.
The FDA completed an inspection of Cerovene Inc. on March 23, 2026 in Valley Cottage, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 23, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Valley Cottage, NY (United States)